MX2020006294A - Composiciones de vacunas y método para elaborarlas. - Google Patents
Composiciones de vacunas y método para elaborarlas.Info
- Publication number
- MX2020006294A MX2020006294A MX2020006294A MX2020006294A MX2020006294A MX 2020006294 A MX2020006294 A MX 2020006294A MX 2020006294 A MX2020006294 A MX 2020006294A MX 2020006294 A MX2020006294 A MX 2020006294A MX 2020006294 A MX2020006294 A MX 2020006294A
- Authority
- MX
- Mexico
- Prior art keywords
- protein
- thrombostasin
- methods
- vaccine compositions
- making same
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 4
- 238000000034 method Methods 0.000 title abstract 3
- 229960005486 vaccine Drugs 0.000 title abstract 3
- 102000004169 proteins and genes Human genes 0.000 abstract 7
- 108090000623 proteins and genes Proteins 0.000 abstract 7
- 102000037865 fusion proteins Human genes 0.000 abstract 3
- 108020001507 fusion proteins Proteins 0.000 abstract 3
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 2
- 238000012217 deletion Methods 0.000 abstract 2
- 230000037430 deletion Effects 0.000 abstract 2
- 230000004927 fusion Effects 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
- C07K14/43563—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects
- C07K14/43577—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from insects from flies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0003—Invertebrate antigens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/20—Fusion polypeptide containing a tag with affinity for a non-protein ligand
- C07K2319/24—Fusion polypeptide containing a tag with affinity for a non-protein ligand containing a MBP (maltose binding protein)-tag
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Insects & Arthropods (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Toxicology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Abstract
En el presente documento se describen proteínas de fusión que comprenden una proteína de trombostasina truncada que tiene al menos un 85% de homología de secuencia con una proteína de trombostasina, en donde la proteína de trombostasina tiene una deleción de carboxi terminal; y una proteína asociada a la fusión que no es una proteína de trombostasina; se describen adicionalmente proteínas trombostasinas de composiciones de vacunas que tienen una deleción de carboxi terminal, y métodos para inhibir una respuesta a una proteína de trombostasina en un huésped que la necesita, que comprenden las proteínas de fusión o composiciones de vacuna descritas; además se describen métodos para la preparación de una composición de proteína de fusión.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762598658P | 2017-12-14 | 2017-12-14 | |
PCT/US2018/065407 WO2019118696A1 (en) | 2017-12-14 | 2018-12-13 | Vaccine compositions and methods of making same |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2020006294A true MX2020006294A (es) | 2020-12-03 |
Family
ID=64959426
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2020006294A MX2020006294A (es) | 2017-12-14 | 2018-12-13 | Composiciones de vacunas y método para elaborarlas. |
Country Status (5)
Country | Link |
---|---|
US (2) | US11780894B2 (es) |
AU (2) | AU2018386128B2 (es) |
BR (1) | BR112020011849A2 (es) |
MX (1) | MX2020006294A (es) |
WO (1) | WO2019118696A1 (es) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6451992B1 (en) | 1998-08-20 | 2002-09-17 | Auburn University | Antithrobin nucleotides and proteins from horn fly |
US9101557B2 (en) * | 2011-04-13 | 2015-08-11 | Auburn University | Combination of protein forms for hornfly vaccination |
-
2018
- 2018-12-13 MX MX2020006294A patent/MX2020006294A/es unknown
- 2018-12-13 US US16/771,800 patent/US11780894B2/en active Active
- 2018-12-13 WO PCT/US2018/065407 patent/WO2019118696A1/en active Application Filing
- 2018-12-13 AU AU2018386128A patent/AU2018386128B2/en active Active
- 2018-12-13 BR BR112020011849-4A patent/BR112020011849A2/pt unknown
-
2023
- 2023-09-06 US US18/242,627 patent/US20240141000A1/en active Pending
-
2024
- 2024-05-30 AU AU2024203626A patent/AU2024203626A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
US20210070818A1 (en) | 2021-03-11 |
US20240141000A1 (en) | 2024-05-02 |
BR112020011849A2 (pt) | 2020-11-24 |
AU2018386128A1 (en) | 2020-07-02 |
US11780894B2 (en) | 2023-10-10 |
WO2019118696A1 (en) | 2019-06-20 |
AU2018386128B2 (en) | 2024-03-07 |
AU2024203626A1 (en) | 2024-06-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2018010824A (es) | Proteinas de union inducibles y metodos de uso. | |
PH12018502361A1 (en) | Gdf15 fusion proteins and uses thereof | |
PH12020550051A1 (en) | Glp-1 compositions and uses thereof | |
UA120917C2 (uk) | Химерний білок фактора viii та його застосування | |
PH12020551019A1 (en) | IL-22 Fc FUSION PROTEINS AND METHODS OF USE | |
MX2020014031A (es) | Proteinas heterodimericas y usos de las mismas. | |
MX2017013949A (es) | Composiciones mectantes a base de seda y sus metodos. | |
MX2020007945A (es) | Proteinas f del rsv estabilizadas y usos de las mismas. | |
BR112015014727B8 (pt) | Composição imunogênica, vacina, e, uso de uma composição imunogênica | |
EP3543335A3 (en) | Soluble intein fusion proteins and methods for purifying biomolecules | |
MX2023014077A (es) | Composiciones de proteina anti-vegf y metodos para producir la misma. | |
MX2020008125A (es) | Composiciones que comprenden berberina. | |
MX2019014397A (es) | Polipeptidos que enlazan adamts5, mmp13 y agrecano. | |
WO2018097603A3 (ko) | 중동호흡기증후군 코로나바이러스 s 단백질 면역원 조성물 및 이의 제작 방법 | |
MY187334A (en) | Xylanase | |
WO2018132821A3 (en) | Elastomeric proteins | |
WO2015150968A3 (en) | Lyophilized pharmaceutical composition of fc-peptide fusion protein | |
PH12020551618A1 (en) | Erenumab compositions and uses thereof | |
MX2020006294A (es) | Composiciones de vacunas y método para elaborarlas. | |
EP3636278A3 (en) | Clostridium difficile immunogenic composition | |
MX2015013808A (es) | Vacuna contra garrapatas rhipicephalus. | |
MX2020008295A (es) | Polipeptidos, composiciones y sus usos. | |
WO2018200814A3 (en) | Modified cyclic peptides and therapeutic use thereof |